|
WO2021070956A1
|
|
siRNA EXPRESSION VECTOR
|
|
WO2021020446A1
|
|
Composition containing herpes simplex virus
|
|
WO2020218419A1
|
|
Aav mutant having brain-targeting property
|
|
KR20210031699A
|
|
DNA polymerase mutant suitable for nucleic acid amplification reaction from RNA
|
|
WO2019212023A1
|
|
Rna virus processing method
|
|
US2021062141A1
|
|
Lymphocyte production method
|
|
WO2019132010A1
|
|
Method, apparatus and program for estimating base type in base sequence
|
|
WO2019017452A1
|
|
Method for detecting presence or absence of non-enveloped rna virus
|
|
KR20200016259A
|
|
Preservation method of oligonucleotide
|
|
JP2018197229A
|
|
Composition for body condition maintaining, body condition enhancement or body condition adjustment
|
|
EP3556854A1
|
|
Heat-resistant reverse transcriptase mutant
|
|
CN109996866A
|
|
Method for generating endothelial cell
|
|
JP2019083789A
|
|
Virus concentration methods
|
|
KR20190043148A
|
|
How to obtain microglia from pluripotent stem cells
|
|
JP2019037149A
|
|
Methods for concentrating virus
|
|
EP3492592A1
|
|
Fibronectin fragment to be used for stem cell production
|
|
JP2017163980A
|
|
Composition for adjusting enterobacterial flora
|
|
US2018362933A1
|
|
Method for producing mesenchymal stem cells
|
|
JP2018038341A
|
|
Highly sensitive detection method of target nucleic acid
|
|
JP2017104091A
|
|
Method for producing mesenchymal cell
|
